Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer

BACKGROUND: Stereotactic ablative radiotherapy (SABR) is a safe and effective modality in patients with liver cancer who are ineligible for other local therapies. However SABR is not current standard of practice and requires further validation. Patient reported quality of life (QOL) is key to this v...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutsaers, Adam, Greenspoon, Jeffrey, Walker-Dilks, Cindy, Swaminath, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492951/
https://www.ncbi.nlm.nih.gov/pubmed/28662680
http://dx.doi.org/10.1186/s13014-017-0818-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492951/
https://www.ncbi.nlm.nih.gov/pubmed/28662680
http://dx.doi.org/10.1186/s13014-017-0818-8

Ejemplares similares